These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22768148)

  • 1. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.
    Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S
    PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
    Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
    Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.
    Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S
    Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
    Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
    Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
    Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
    Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release.
    Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLAC4 is upregulated in severe early onset preeclampsia and upregulated with syncytialisation but not hypoxia.
    Tuohey L; Macintire K; Ye L; Palmer K; Skubisz M; Tong S; Kaitu'u-Lino TJ
    Placenta; 2013 Mar; 34(3):256-60. PubMed ID: 23312075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane and soluble forms of endoglin in preeclampsia.
    Oujo B; Perez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
    Curr Mol Med; 2013 Sep; 13(8):1345-57. PubMed ID: 23826920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
    Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endoglin and its soluble form in pathogenesis of preeclampsia.
    Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Vavoulidis E; Gullo G; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
    Mol Cell Biochem; 2022 Feb; 477(2):479-491. PubMed ID: 34783962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.